<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Clinical Research &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/clinical-research/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 30 Dec 2025 05:51:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Clinical Research &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>MDMA Therapy for Eating Disorders: Insights and Future</title>
		<link>https://bioengineer.org/mdma-therapy-for-eating-disorders-insights-and-future/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 30 Dec 2025 05:50:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical evidence]]></category>
		<category><![CDATA[Clinical Research]]></category>
		<category><![CDATA[Eating disorder treatment]]></category>
		<category><![CDATA[Eating disorders]]></category>
		<category><![CDATA[innovative therapies]]></category>
		<category><![CDATA[MDMA therapy]]></category>
		<category><![CDATA[MDMA-assisted therapy]]></category>
		<category><![CDATA[Neurotransmitter mechanisms]]></category>
		<category><![CDATA[Psychedelic research]]></category>
		<category><![CDATA[psychedelic treatment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mdma-therapy-for-eating-disorders-insights-and-future/</guid>

					<description><![CDATA[In recent years, the exploration of psychedelic substances for therapeutic purposes has gained momentum, shifting the narrative around their safety and efficacy. Among these, MDMA, commonly known as ecstasy, has emerged as a significant contender in the field of mental health treatment, particularly its application in addressing complex disorders such as eating disorders. A groundbreaking [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312259</post-id>	</item>
		<item>
		<title>Ketamine’s Efficacy in Treating Depression and Eating Disorders</title>
		<link>https://bioengineer.org/ketamines-efficacy-in-treating-depression-and-eating-disorders/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Dec 2025 07:02:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Research]]></category>
		<category><![CDATA[Eating disorders]]></category>
		<category><![CDATA[Ketamine treatment]]></category>
		<category><![CDATA[psychiatric therapies]]></category>
		<category><![CDATA[treatment-resistant depression]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ketamines-efficacy-in-treating-depression-and-eating-disorders/</guid>

					<description><![CDATA[In a groundbreaking study led by researchers including Wassenaar, Blalock, and Duffy, the use of ketamine as a treatment for individuals battling both treatment-resistant depression and eating disorders has emerged as a compelling area of focus. This research is not just timely; it marks a significant advancement in mental health treatment, especially as traditional therapies [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">305537</post-id>	</item>
		<item>
		<title>Beta-Blockers and Parkinson’s Disease Progression Unveiled</title>
		<link>https://bioengineer.org/beta-blockers-and-parkinsons-disease-progression-unveiled/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 03 Jul 2025 08:15:32 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Beta-Adrenoceptor Drugs]]></category>
		<category><![CDATA[Clinical Research]]></category>
		<category><![CDATA[Neuroinflammation]]></category>
		<category><![CDATA[Parkinson's Disease Progression]]></category>
		<category><![CDATA[Synucleinopathy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/beta-blockers-and-parkinsons-disease-progression-unveiled/</guid>

					<description><![CDATA[In recent years, the search for therapeutic strategies that could slow or prevent the progression of Parkinson’s disease (PD) has intensified dramatically. A groundbreaking study published in npj Parkinson’s Disease now sheds new light on the potential role of beta-adrenoceptor drugs in modulating disease progression. This robust investigation pooled data from multiple cohorts to evaluate [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">251299</post-id>	</item>
		<item>
		<title>Team describes science-based hiccups intervention</title>
		<link>https://bioengineer.org/team-describes-science-based-hiccups-intervention/</link>
					<comments>https://bioengineer.org/team-describes-science-based-hiccups-intervention/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 18 Jun 2021 16:53:02 +0000</pubDate>
				<category><![CDATA[Science News]]></category>
		<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Clinical Research]]></category>
		<category><![CDATA[Healthcare Technology]]></category>
		<category><![CDATA[Hiccup Relief]]></category>
		<category><![CDATA[medical innovation]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Neural Stimulation]]></category>
		<category><![CDATA[Technology Transfer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/team-describes-science-based-hiccups-intervention/</guid>

					<description><![CDATA[Users reported relief in 92% of cases, with high degrees of effectiveness and ease of use SAN ANTONIO (June 18, 2021) &#8212; Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published June 18 [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/team-describes-science-based-hiccups-intervention/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172049</post-id>	</item>
	</channel>
</rss>
